Health ❯ Healthcare ❯ Patient Care ❯ Chronic Conditions

Obesity Management

Medicare Launches GLP‑1 Bridge to Offer Select Weight‑Loss Drugs for $50 a Month

An 18‑month CMS demonstration aims to lower out‑of‑pocket costs for eligible beneficiaries to collect data that will guide whether Medicare should extend coverage

27 ARTICLES

4mo ago

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

3 ARTICLES

9mo ago

UK ‘Postcode Lottery’ for Weight-Loss Jabs Persists as Generics Line Up for 2026

3 ARTICLES

last yr.

Orforglipron Pill Cuts Weight 11–12% in Pivotal Phase 3 Trial

17 ARTICLES

last yr.

Eli Lilly’s Oral Obesity Pill Triggers Stock Slide After Modest Weight-Loss Results

Obesity Management

Medicare Launches GLP‑1 Bridge to Offer Select Weight‑Loss Drugs for $50 a Month

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

Oxford Review Finds Rapid Weight Regain After Stopping GLP-1 Drugs

FDA-Cleared Wegovy Pill Becomes First Oral GLP-1 for Weight Loss

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity

UK ‘Postcode Lottery’ for Weight-Loss Jabs Persists as Generics Line Up for 2026

Orforglipron Pill Cuts Weight 11–12% in Pivotal Phase 3 Trial

Eli Lilly’s Oral Obesity Pill Triggers Stock Slide After Modest Weight-Loss Results